New Lead Assumed Position at IUAD
Insurance United Against Dementia (IUAD) Campaign Reaches Initial Fundraising Target and Announces Second Phase
The Insurance United Against Dementia (IUAD) campaign, an industry-led initiative established in partnership with Alzheimer's Society, has achieved its initial £10 million fundraising target, set in 2017. This significant milestone marks the beginning of the campaign's second phase, which focuses on translating research and development into practical, accessible clinical care pathways.
The second phase of the IUAD campaign aims to build an infrastructure to support the administration of new amyloid-targeting treatments (ATTs) for Alzheimer’s disease and dementia. These treatments, such as lecanemab and donanemab, slow disease progression but carry safety risks that require specialized management.
Key objectives of this phase include developing clinical and healthcare system infrastructure to deliver these treatments responsibly, facilitating informed patient consent and comprehensive caregiver support, enabling appropriate safety monitoring, and coordinating multidisciplinary care to optimize treatment compliance and outcomes for patients with mild cognitive impairment and mild dementia due to Alzheimer’s.
Chris Lay, the CEO of Marsh McLennan UK, has been appointed as the new Campaign Chair for IUAD. The Insurance Day of Giving, a fundraising event for Alzheimer's Society, is a chance for people in the insurance sector to contribute to the fight against dementia. The exact amount of money raised beyond £10 million is not specified, but the next Insurance Day of Giving will take place on Thursday, 1st December 2022.
The Insurance Day of Giving is a significant event in the insurance sector, with many people participating. It is a cause that is close to the hearts of many in the industry due to the impact of dementia. The source of the information about the Insurance Day of Giving and the IUAD campaign can be found on alzheimers.org.uk/iuad.
The IUAD campaign is led by leaders from across the insurance industry, working together to make a difference during the festive season and beyond. The second phase of the campaign represents a shift from fundraising to translating research and development into practical, accessible clinical care pathways, leveraging the £10 million raised initially to implement these advanced treatment modalities effectively and safely across healthcare systems.
- The second phase of the Insurance United Against Dementia (IUAD) campaign will focus on translating research and development into practical, accessible clinical care pathways, such as the administration of new amyloid-targeting treatments (ATTs) for Alzheimer’s disease and dementia.
- In the insurance sector, events like the Insurance Day of Giving play a significant role in contributing to the fight against dementia, with many people participating due to the impact of medical-conditions like dementia.
- The IUAD campaign, a business initiative led by leaders from across the insurance industry, aims to utilize the £10 million raised initially to implement advanced treatment modalities effectively and safely during the second phase, shifting from fundraising to translating research and development into practical care pathways.
